Earnings Preview: Lemonade, Inc. revenue expected to increase by 81.38%, institutional views are mixed

Earnings Agent
Jul 22

Abstract

Lemonade, Inc. will report on July 29, 2026 Pre-MKt; this preview outlines the latest market estimates, last quarter’s performance, and scenario analysis around revenue, profitability, and adjusted EPS dynamics.

Market Forecast

Consensus for the current quarter points to revenue of 290.88 million US dollars, with an implied year-over-year increase of 81.38%, EBIT near a loss of 45.20 million US dollars with an implied 23.30% year-over-year improvement, and adjusted EPS around -0.56 with an implied 29.65% year-over-year improvement. The company’s operating metrics last quarter suggest gross profit margin near 48.33% and net profit margin around -13.88%, providing a reference baseline; the current quarter margin trajectory is expected to reflect continued efficiency gains, though exact gross and net margin forecasts were not disclosed.

The core engine remains insurance revenue anchored by net earned premium and ceded commission economics, with management focused on underwriting discipline and expense control as the product mix scales. The most promising area is net premium, estimated at 212.60 million US dollars last quarter, aided by pricing actions and retention; the segment remains the primary contributor and growth lever on a year-over-year basis.

Last Quarter Review

The previous quarter delivered revenue of 258.00 million US dollars, up 70.64% year over year, with a gross profit margin of 48.33%, GAAP net profit attributable to shareholders at -35.80 million US dollars, a net profit margin of -13.88%, and adjusted EPS of -0.47, improving 45.35% year over year. Cost discipline and improving loss-ratio trends supported better-than-expected profitability as EBIT of -34.60 million US dollars topped internal and external expectations.

Business momentum was broad-based, led by net premium of 212.60 million US dollars, with commissions and other revenue at 12.00 million US dollars and net investment income at 9.80 million US dollars, underscoring stronger scale and rate adequacy.

Current Quarter Outlook

Main business trajectory

The company’s core revenue drivers are embedded in net earned premium, supported by reinsurance structure and commissions. With consensus revenue at 290.88 million US dollars, year-over-year growth of 81.38% would reflect sustained policy-in-force expansion and rate resets flowing through earnings. Margin signals from last quarter’s 48.33% gross margin and the improved adjusted EPS trajectory suggest continued operating leverage as marketing efficiency and underwriting performance improve. The key to sustaining this trajectory is maintaining pricing power and retention while keeping loss-cost inflation contained, which would allow further improvement in expense ratios and reduce the EBIT loss closer to the 45.20 million US dollars consensus.

Most promising growth vector

Net premium remains the largest growth driver and the clearest path toward scale benefits. Last quarter’s 212.60 million US dollars contribution points to robust earning of previously written premium, and the current quarter’s revenue outlook implies faster monetization of the in-force book. Mixed revenue from ceded commissions and investment income provides incremental support, but the principal sensitivity is still loss ratios; if claims frequency and severity remain benign relative to pricing, the year-over-year improvement embedded in EPS (-0.56 expected, a 29.65% improvement) becomes more achievable. Over the medium term, favorable seasonality and cautious growth in higher-margin product lines could further narrow the EBIT loss run-rate.

Key stock-price swing factors this quarter

The first driver is revenue beat or miss versus the 290.88 million US dollars consensus, which would validate policy growth and pricing durability. The second is profitability cadence: investors will focus on the gap between the -45.20 million US dollars EBIT estimate and actual results, as well as any commentary indicating sustained improvements in loss and expense ratios. The third is margin guidance and mix; while explicit gross and net margin forecasts were not provided, qualitative color on reinsurance costs, pricing, and claims inflation could reset expectations for adjusted EPS. Any signs of accelerating cash generation or a path to breakeven would likely have an outsized impact on the share price.

Analyst Opinions

The majority of recent previews echo a cautiously optimistic stance, emphasizing substantial top-line growth alongside gradual loss-ratio normalization and operating leverage, but still projecting a GAAP loss. The prevailing view highlights the potential for an upside surprise on revenue given prior-quarter momentum and a measurable improvement in EPS versus last year, provided claims trends remain stable. Several well-known research desks have framed the quarter as a test of sustainability for margin gains, favoring evidence of disciplined growth over sheer customer acquisition, with outlook commentary on pricing and reinsurance costs flagged as the primary catalysts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10